Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inosine 5'-monophosphate dehydrogenase (IMPDH) is a rate-limiting enzyme that catalyzes the conversion of
IMP
to xanthosine monophosphate (XMP) at the branch point of purine nucleotide biosynthesis, leading to the generation of guanine nucleotides. Inhibition of IMPDH results in the depletion of guanine nucleotides, prevents cell growth by G1 arrest, and induces cell differentiation in a cell-type-specific manner. The molecular and sensing mechanisms underlying these effects are not clear. We have examined the induction of apoptosis by mycophenolic acid (MPA), a specific IMPDH inhibitor, in interleukin-3 (IL-3)-dependent murine hematopoietic cell lines. MPA treatment, at clinically relevant doses, caused apoptosis in 32D myeloid cells and in FL5.12 and BaF3 pre-B cells in the ongoing presence of IL-3. Apoptosis was completely prevented by the addition of guanosine at time points up to 12 hours, after which caspase 3 activity increased and apoptosis was not reversible. MPA treatment caused marked down-regulation of the
MAP kinase kinase
/extracellular regulatory kinase (
MEK
/Erk) pathway at 3 hours while simultaneously increasing the phosphorylation of c-Jun kinase. In addition, MPA strongly down-regulated the mammalian target of rapamcyin (mTOR) pathway, as indicated by the decreased phosphorylation of p70 S6 kinase and of 4EBP1. Inhibition of either the mitogen-activated protein kinase (MAPK) or the mTOR pathway alone by standard pharmacologic inhibitors did not induce apoptosis in IL-3-dependent cells, whereas inhibition of both pathways simulated the effects of MPA treatment. These results indicate that IMPDH inhibitors may be effective in modulating signal transduction pathways in hematopoietic cells, suggesting their usefulness in chemotherapeutic regimens for hematologic malignancies.
...
PMID:Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. 1260 35
The E3 ubiquitin ligase
IMP
(impedes mitogenic signal propagation) was isolated as a novel Ras effector that negatively regulates ERK1/2 activation. Current evidence suggests that
IMP
limits the functional assembly of Raf/
MEK
complexes by inactivation of the KSR1 adaptor/scaffold protein. Interaction with Ras-GTP stimulates
IMP
autoubiquitination to relieve limitations on KSR function. The elevated sensitivity of
IMP
-depleted cells to ERK1/2 pathway activation suggests
IMP
acts as a signal threshold regulator by imposing reversible restrictions on the assembly of functional Raf/
MEK
/ERK kinase modules. These observations challenge commonly held concepts of signal transmission by Ras to the MAPK pathway and provide evidence for the role of amplitude modulation in tuning cellular responses to ERK1/2 pathway engagement. Here we describe details of the methods, including RNA interference, ubiquitin ligase assays, and protein complex analysis, that can be used to display the Ras-sensitive contribution of
IMP
to KSR-dependent modulation of the Raf/
MEK
/ERK pathway.
...
PMID:Ras-sensitive IMP modulation of the Raf/MEK/ERK cascade through KSR1. 1675 28
The Ras effector and ubiquitin-protein isopeptide ligase family member
IMP
acts as a steady-state resistor within the Raf-
MEK
-ERK kinase module.
IMP
concentrations are regulated by Ras through induction of autodegradation and can modulate signal/response thresholds by directly limiting the assembly of functional KSR1-dependent Raf.
MEK
complexes. Here, we show that the capacity of
IMP
to inhibit signal propagation through Raf to
MEK
is a consequence of disrupting KSR1 homooligomerization and B-Raf/c-Raf hetero-oligomerization. This impairs both the recruitment of
MEK
to activated Raf family members and the contribution of Raf oligomers to c-Raf kinase activation. Our observations indicate that human KSR1 proteins promote assembly of multivalent Raf.
MEK
complexes that are required for c-Raf kinase activation and functional coupling of active kinases to downstream substrates. This property is engaged by
IMP
for modulation of signal amplitude.
...
PMID:IMP modulates KSR1-dependent multivalent complex formation to specify ERK1/2 pathway activation and response thresholds. 1833 45
The Ras effector and E3 ligase family member
IMP
(impedes mitogenic signal propagation) acts as a steady-state resistor within the Raf-
MEK
-ERK kinase module.
IMP
concentrations are directly regulated by Ras, through induction of autoubiquitination, to permit productive Raf-
MEK
complex assembly. Inhibition of Raf-
MEK
pathway activation by
IMP
occurs through the inactivation of KSR, a scaffold/adapter protein that couples activated Raf to its substrate
MEK1
. The capacity of
IMP
to inhibit signal propagation through Raf to
MEK
is, in part, a consequence of disrupting KSR1 homo-oligomerization and c-Raf-B-Raf hetero-oligomerization. These observations suggest that
IMP
functions as a threshold modulator, controlling sensitivity of the cascade to stimulus by directly limiting the assembly of functional KSR1-dependent Raf-
MEK
complexes.
...
PMID:Signaling threshold regulation by the Ras effector IMP. 1909 43
Xenopus Vg1RBP is a member of the highly conserved
IMP
family of four KH-domain RNA binding proteins, with roles in RNA localization, translational control, RNA stability, and cell motility. Vg1RBP has been implicated in localizing Vg1 mRNAs to the vegetal cortex during oogenesis, in a process mediated by microtubules and microfilaments, and in migration of neural crest cells in embryos. Using c-mos morpholino, kinase inhibitors, and constitutely active recombinant kinases we show that Vg1RBP undergoes regulated phosphorylation by Erk2 MAPK during meiotic maturation, on a single residue, S402, located between the KH2 and KH3 domains. Phosphorylation temporally correlates with the release of Vg1 mRNA from its tight cortical association, assayed in lysates in physiological salt buffers, but does not affect RNA binding, nor self-association of Vg1RBP. U0126, a MAP kinase inhibitor, prevents Vg1RBP cortical release and Vg1 mRNA solubilization in meiotically maturing eggs, while injection of
MKK6
-DD, a constitutively activated
MAP kinase kinase
, promotes the release of both Vg1RBP and Vg1 mRNA from insoluble cortical structures. We propose that Erk2 MAP kinase phosphorylation of Vg1RBP regulates the protein:protein-mediated association of Vg1 mRNP with the cytoskeleton and/or ER. Since the MAP kinase site in Vg1RBP is conserved in several
IMP
homologs, this modification also has important implications for the regulation of
IMP
proteins in somatic cells.
...
PMID:Vg1RBP phosphorylation by Erk2 MAP kinase correlates with the cortical release of Vg1 mRNA during meiotic maturation of Xenopus oocytes. 1937 27
The responses of macrophages to Bacillus anthracis infection are important for the survival of the host, since macrophages are required for the germination of B. anthracis spores in lymph nodes, and macrophage death exacerbates anthrax lethal toxin (LeTx)-induced organ collapse. To elucidate the mechanism of macrophage cell death induced by LeTx, we performed a genetic screen to search for genes associated with LeTx-induced macrophage cell death. RAW264.7 cells, a macrophage-like cell line sensitive to LeTx-induced death, were randomly mutated and LeTx-resistant mutant clones were selected. AMP deaminase 3 (AMPD3), an enzyme that converts AMP to
IMP
, was identified to be mutated in one of the resistant clones. The requirement of AMPD3 in LeTx-induced cell death of RAW 264.7 cells was confirmed by the restoration of LeTx sensitivity with ectopic reconstitution of AMPD3 expression. AMPD3 deficiency does not affect LeTx entering cells and the cleavage of
mitogen-activated protein kinase kinase
(
MKK
) by lethal factor inside cells, but does impair an unknown downstream event that is linked to cell death. Our data provides new information regarding LeTx-induced macrophage death and suggests that there is a key regulatory site downstream of or parallel to
MKK
cleavage that controls the cell death in LeTx-treated macrophages.
...
PMID:AMPD3 is involved in anthrax LeTx-induced macrophage cell death. 2182 1